[TEVA] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
03-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 109.15%
YoY- 81.90%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 3,982,000 4,357,000 4,295,000 5,065,000 5,630,000 4,810,000 4,982,000 -3.66%
PBT 144,000 -33,000 -84,000 1,254,000 688,000 867,000 557,000 -20.16%
Tax 62,000 -59,000 9,000 46,000 54,000 228,000 104,000 -8.25%
NP 77,000 69,000 -105,000 1,055,000 580,000 570,000 446,000 -25.35%
Tax Rate -43.06% - - -3.67% -7.85% -26.30% -18.67% -
Total Cost 3,905,000 4,288,000 4,400,000 4,010,000 5,050,000 4,240,000 4,536,000 -2.46%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin 1.93 1.58 -2.44 20.83 10.30 11.85 8.95 -22.54%
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS 0.07 0.06 -0.10 1.04 0.57 0.62 0.52 -28.38%
EPS Diluted 0.07 0.06 -0.10 1.03 0.57 0.62 0.52 -28.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.